Noveltreat 1.7 mg Pre-filled Pen

The Noveltreat 1.7 mg pen is used to deliver semaglutide. Semaglutide, the active ingredient in Noveltreat, is a GLP-1 (glucagon-like peptide-1) receptor agonist that reduces the hunger cravings and increases the feeling of fullness an individual may experience after eating. The Noveltreat 1.7 mg injectable pen can be used for weight loss, obesity, or even individuals who have Type 2 diabetes. 

Key Features

How does Noveltreat 1.7 mg work?

Semaglutide is the active ingredient that’s delivered by the Noveltreat 1.7 mg pre-filled pen. It’s a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the GLP-1 hormone. The GLP-1 hormone is naturally produced by the gut. This GLP pathway is used by the Noveltreat 1.7 mg pen to reduce the hunger cravings an individual experiences and increase the feeling of satiety they may have after eating. It basically targets the brain areas that are involved in both of these processes. 

Semaglutide also slows down how quickly food is digested. Since food moves slowly through the stomach, a person is able to feel fuller for longer. This slow movement also helps in releasing glucose steadily, which maintains the blood sugar levels too. 

Dosage

Any individual should speak with their healthcare provider before starting to take Noveltreat 1.7 mg, but here are a few guidelines that should be kept in mind:

• It’s typically recommended to take this pen just once a week.
• Make sure that you administer the medication at the same time every week.
• The abdomen, thighs, and upper arm areas are the top locations where you can inject the Noveltreat 1.7 mg.
• You should keep rotating your injection sites. The general area of administration can remain the same, though. 
• If you end up missing a dose, then try to take it as soon as you remember. Although, if your next dose is scheduled in just 2 days, i.e., 48 hours, then you should skip the missed dose. 

Uses

Noveltreat 1.7 mg is typically suggested in the following situations:

• For weight loss
• To manage Type-2 diabetes in individuals
• To treat chronic obesity

Side Effects

Some mild side effects you may see are:

• Mild abdominal discomfort
• Fatigue
• Dizziness
• Vomiting
• Headaches
• Nausea 
• Diarrhea
• Constipation

Rare but serious side effects you should watch out for:

• Signs of pancreatitis 
• Decreased urination or swelling in legs, ankles, or feet.
• Thyroid risks like a lump or swelling in the neck.
• Extreme allergic reactions like swelling in the facial area, lips, or throat.
• Changes in vision.
• Extremely low blood sugar

Try to immediately contact your healthcare provider if you experience any of these serious side effects.

Interactions

Insulin & Diabetes medications

Pairing the Noveltreat 1.7 mg pre-filled pen with other insulin medications or any other medications that decrease blood sugar has the potential of making the individual experience hypoglycemia, i.e., have a blood sugar level that’s too low. 

Oral Medications & Contraceptives

Taking oral medications with Noveltreat 1.7 mg can be tricky since semaglutide affects how soon the medications get absorbed by the body because it slows down digestion. It’s best to have it at another time. 

Blood thinners

Noveltreat can influence how effective blood thinners can be. If you are using any blood thinners like warfarin or others, then you should pay attention to your blood clotting time for your safety. 

Water pills

Taking Noveltreat 1.7 mg with water pills like diuretics can make you lose water and weight very fast. Because of this, you suffer the risk of being extremely dehydrated. It’s best to get your dosage checked before you start any course. 

Blood pressure medications

If you’re taking blood pressure medications, then you should be cautious of taking Noveltreat 1.7 mg with them since that can lower blood pressure too. It can cause several complications so it’s best to be cautious when using them. 

Precautions and Safety Warnings

• People who have pancreatic conditions or have a history of it should avoid. 
• Individuals who have thyroid problems should also use Noveltreat 1.7 mg with caution or avoid it if their healthcare provider suggests. 
• Noveltreat 1.7 mg should be avoided by women who plan to conceive in 2 months since using it during pregnancy is not recommended. 
• Kidney and gallbladder issues can arise due to losing weight rapidly and due to the dehydration it can cause. 
• Since semaglutide slows down digestion, people who have severe gastroparesis or stomach paralysis should be wary of using the Noveltreat 1.7 mg pen. 

Conclusion

Semaglutide pens have brought about a new wave in the field of obesity research and weight management. The Noveltreat 1.7 pen is mainly used by individuals to lose weight and also help them reduce their blood sugar levels. Semaglutide uses an innovatory approach since it utilizes the natural GLP-1 pathways that the body already has available. It’s highly recommended to have a healthy diet that’s low in calories as well as to exercise sufficiently when using this medication.  

FAQ’s